Continued the debate
Chaffey supported the bill as a sensible technical measure that aligns the levy with its original policy intent by ensuring the current responsible entity for a medical device pays the levy. The member argued this change allows the system to adapt to commercial shifts, such as transfers of device listings between companies. Chaffey also included validating provisions to mitigate legal risks from previous levy collections. While endorsing the bill, the member criticised the government for failing to secure a new national health reform agreement and for delays in releasing home-care packages, which contribute to bed blocking and delayed elective surgeries.